CLAZ

Claritas Pharmaceuticals, Inc. Stock Price

OTCPK:CLAZ.F Community·US$37.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CLAZ.F Share Price Performance

US$0.000001
-0.00 (-90.00%)
US$0.000001
-0.00 (-90.00%)
Price US$0.000001

CLAZ.F Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slight risk with weak fundamentals.

4 Risks
0 Rewards

Claritas Pharmaceuticals, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

-US$1.8m

Other Expenses

US$1.8m

Earnings

Last Reported Earnings
Sep 30, 2021
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About CLAZ.F

Founded
2014
Employees
n/a
CEO
Robert Farrell
Website
n/a

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.

Recent CLAZ.F News & Updates

Recent updates

No updates